OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 53-66
Open Access | Times Cited: 326

Showing 26-50 of 326 citing articles:

The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline
Cecilia Boccalini, Federica Ribaldi, Inès Hristovska, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 221-233
Open Access | Times Cited: 39

APOE effects on regional tau in preclinical Alzheimer’s disease
Christina B. Young, Emily Johns, Gabriel Kennedy, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 37

Myelin in Alzheimer’s disease: culprit or bystander?
Michel Maître, Hélène Jeltsch‐David, Nwife Getrude Okechukwu, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 32

Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
Meina Quan, Shuman Cao, Qi Wang, et al.
Phenomics (2023) Vol. 3, Iss. 4, pp. 333-349
Open Access | Times Cited: 32

Age-related and amyloid-beta-independent tau deposition and its downstream effects
Anika Wuestefeld, Alexa Pichet Binette, David Berron, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3192-3205
Open Access | Times Cited: 29

Neutrophils as a potential therapeutic target in Alzheimer’s disease
Michelle L. Aries, Tiffany Hensley‐McBain
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
Francheska Delgado‐Peraza, Carlos Nogueras‐Ortiz, Anja Hviid Simonsen, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 26

Diagnosis and Management of Posterior Cortical Atrophy
Keir Yong, Jonathan Graff‐Radford, Samrah Ahmed, et al.
Current Treatment Options in Neurology (2023) Vol. 25, Iss. 2, pp. 23-43
Open Access | Times Cited: 24

Tipping points in neurodegeneration
Mikael Simons, Johannes Levin, Martin Dichgans
Neuron (2023) Vol. 111, Iss. 19, pp. 2954-2968
Open Access | Times Cited: 24

Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies
Lijiao Zu, Xicheng Wang, Peng Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 14

Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
Qiang Zhang, Guanhu Yang, Yuan Luo, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13

Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Amal Kaddoumi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1914-1914
Open Access | Times Cited: 12

Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases
Masanori Kurihara, Tomoyasu Matsubara, Satoru Morimoto, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 10

What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries
Nicolas Villain, Robin Michalon
European Journal of Neurology (2024) Vol. 31, Iss. 11
Open Access | Times Cited: 10

Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 9

APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APPNL-G-F cerebral organoid model of Alzheimer’s disease
Hang Liu, Fan Mei, Rongrong Ye, et al.
Cell Research (2024) Vol. 34, Iss. 6, pp. 451-454
Closed Access | Times Cited: 8

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew S. Macauley
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101111-101111
Closed Access | Times Cited: 36

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Anna H. Boerwinkle, Brian A. Gordon, Julie K. Wisch, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 55-65
Open Access | Times Cited: 29

Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
Ying Han, Daozhou Liu, Ying Cheng, et al.
Redox Biology (2023) Vol. 63, pp. 102734-102734
Open Access | Times Cited: 21

Silver nanoparticle-based SERS sensors for sensitive detection of amyloid-β aggregates in biological fluids
Olga E. Eremina, Nikita R. Yarenkov, Gulia I. Bikbaeva, et al.
Talanta (2023) Vol. 266, pp. 124970-124970
Closed Access | Times Cited: 21

Scroll to top